Altimmune (ALT) Change in Cash (2010 - 2026)

Altimmune (ALT) has reported Change in Cash for 17 consecutive years, with $53.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash rose 342.12% year-over-year to $53.8 million; the TTM figure through Mar 2026 stood at $48.5 million (up 262.34% YoY), while the FY2025 annual figure was $6.8 million, up 106.96% from the prior year.
• Change in Cash advanced to $53.8 million in Q1 2026 per ALT's latest filing, from -$17.5 million in the prior quarter.
• Across five years, Change in Cash topped out at $134.0 million in Q2 2025 and bottomed at -$121.9 million in Q3 2025.
• Historically, Change in Cash has averaged -$5.5 million across 5 years, with a median of -$10.4 million in 2022.
• Annual changes were most pronounced in 2022 — Change in Cash sank 1202.89% — and 2025, when it surged 713.28%.
• Altimmune's Change in Cash stood at -$16.4 million in 2022, then surged by 394.86% to $48.3 million in 2023, then sank by 88.7% to $5.5 million in 2024, then tumbled by 420.54% to -$17.5 million in 2025, then jumped by 408.09% to $53.8 million in 2026.
• Business Quant data shows ALT's Change in Cash at $53.8 million in Q1 2026, -$17.5 million in Q4 2025, and -$121.9 million in Q3 2025.